AstraZeneca Shares Plunge as Human Trial for COVID-19 Vaccine Is Halted Due To “Adverse Reaction”

The COVID-19 vaccine by AstraZeneca and the University of Oxford was in Phase 3 testing on humans at dozens of sites across the US, but has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.